Durham University, United Kingdom.
University of Liverpool, Liverpool, United Kingdom & RMIT University, Victoria, Australia.
Int J Drug Policy. 2021 Sep;95:103270. doi: 10.1016/j.drugpo.2021.103270. Epub 2021 May 8.
Drug checking is a health service whose behavioural outcomes have been assessed primarily through reported intentions of service users after receiving healthcare consultations or brief interventions (BIs). This study contributes to the evidence base through utilising a follow-up design to compare outcomes of risk communications on risk management and harm reduction practices both at and after attending drug checking services at three English music festivals in 2017.
Data were collected and analysed from: (i) 1,482 self-complete questionnaires at sample drop-off; (ii) 1,482 nominated primary service users at 1,482 face-to-face BIs; and (iii) an anonymous online self-report follow-up survey completed by a sub-sample of 130 primary service users (one quarter of legible, functioning email addresses received) followed up three months later. Ten measures (one verified action and nine intentions) were recorded at point of BI and compared with retrospectively reported outcomes and ongoing changes post-BI.
Outcomes at follow-up were correlated with actions and intentions at BI for nine of the ten measures, including over half of service users disposing of samples identified as other than expected and two in five reporting reduced dosage for samples identified as expected. One in five reported alerting their friends to substances of concern.
Event-based drug checking services can access and engage productively with young adults earlier in drug taking careers and not in touch with health services, through tailored polydrug BIs. Rapid identification of substances of concern, dissemination of test results and associated risk communications during and after events through friendship networks, support services and early warning systems suggest that the benefits of drug checking can extend beyond service users and point of BI and can increase strategies and behaviours to reduce drug-related harm such as poisoning and overdose.
药物检测是一项健康服务,其行为结果主要通过接受医疗保健咨询或简短干预(BI)后服务使用者的报告意图来评估。本研究通过使用随访设计,比较了在 2017 年三个英国音乐节上参加药物检测服务时和之后的风险管理和减少伤害实践的风险沟通结果,为证据基础做出了贡献。
数据来自:(i)样本送达时的 1482 份自我完成的问卷;(ii)1482 名指定的主要服务使用者在 1482 次面对面 BI 中的提名;(iii)三个月后由 130 名主要服务使用者(可辨认、正常运作的电子邮件地址的四分之一)匿名在线自我报告的随访调查。在 BI 时记录了十个措施(一个验证的行为和九个意图),并与回顾性报告的结果和 BI 后持续变化进行比较。
随访结果与 BI 时的行为和意图相关的有十个措施中的九个,包括超过一半的服务使用者处置了识别为非预期的样本,五分之二的报告减少了识别为预期的样本的剂量。五分之一的人报告提醒他们的朋友注意有问题的物质。
基于事件的药物检测服务可以通过针对多药物 BI,在药物使用生涯早期、未接触卫生服务的情况下,与年轻成年人接触并有效地接触。在活动期间和之后,通过友谊网络、支持服务和预警系统快速识别有问题的物质、传播测试结果和相关风险沟通,表明药物检测的好处不仅可以延伸到服务使用者和 BI 点,还可以增加减少与药物相关的伤害的策略和行为,如中毒和过量。